Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Inovio Pharma

Start price
Target price
Perf. (%)
€9.50
28.01.21
€14.00
23.16%
04.02.21

Risky Investment
High risks for its business
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€54.79
27.01.21
-
27.01.22
6.17%
28.07.21

buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€5.64
27.01.21
€8.00
27.01.22
9.75%
28.09.21

Could be worthwhile Investment >10% per year
buy
Supernus Pharmaceuticals

Start price
Target price
Perf. (%)
€25.20
25.01.21
€28.00
25.01.22
3.97%
26.01.22

Could be worthwhile Investment >10% per year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€173.98
25.01.21
€250.00
25.01.22
23.00%
17.01.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€22.08
25.01.21
€35.00
30.39%
08.02.21

Could be worthwhile Investment >10% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€63.50
24.01.21
-
24.01.22
-15.72%
11.03.21

Could be worthwhile Investment >10% per year
buy
Eledon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€13.36
23.01.21
€100.00
23.01.22
-77.10%
24.01.22

Could be very worthwhile Investment >20% year
buy
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.62
23.01.21
€60.00
23.01.22
-81.94%
24.01.22

Could be very worthwhile Investment >20% year
buy
Arca Biopharma

Start price
Target price
Perf. (%)
€3.98
23.01.21
€30.00
23.01.22
-60.05%
24.01.22

Could be very worthwhile Investment >20% year
buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.19
23.01.21
€20.00
23.01.22
-51.51%
24.01.22

Could be very worthwhile Investment >20% year
buy
Hexo Corp.

Start price
Target price
Perf. (%)
€75.60
23.01.21
-
23.01.22
-75.74%
08.11.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good culture
Future proof or reliable business model
buy
Teligent Inc.

Start price
Target price
Perf. (%)
€0.99
23.01.21
-
23.01.22
-97.97%
24.01.22

Could be very worthwhile Investment >20% year
buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€31.33
23.01.21
-
23.01.22
-55.15%
24.01.22

Could be very worthwhile Investment >20% year
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.86
23.01.21
€3.00
23.01.22
-38.46%
24.01.22

Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Purple Biotech Ltd. ADR

Start price
Target price
Perf. (%)
€3.52
21.01.21
€60.00
21.01.23
-54.26%
21.01.23

Could be very worthwhile Investment >20% year
buy
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€28.25
21.01.21
€120.00
21.01.23
-86.83%
21.01.23

Could be very worthwhile Investment >20% year
buy
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€2.50
21.01.21
€10.00
21.01.22
-47.52%
22.01.22

Could be very worthwhile Investment >20% year
buy
Lipocine Inc.

Start price
Target price
Perf. (%)
€32.30
21.01.21
€136.00
21.01.22
-57.58%
22.01.22

Could be very worthwhile Investment >20% year
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€134.68
20.01.21
€144.00
0.89%
02.02.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
buy
GSK plc

Start price
Target price
Perf. (%)
€15.90
20.01.21
€16.50
20.01.22
1.31%
27.01.21

Small cyclical dependencies
Could be worthwhile Investment >10% per year
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€87.23
20.01.21
-
20.01.22
-1.82%
29.03.21

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Standard Investments for future growth
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.31
19.01.21
€67.00
19.01.22
14.53%
20.01.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
buy
Formycon AG

Start price
Target price
Perf. (%)
€60.40
18.01.21
€80.00
18.01.22
-9.93%
04.10.21

Could be worthwhile Investment >10% per year